Urinary Incontinence

FDA Clears New Sling System As Treatment Option In Women

Published in Women's Health Weekly, September 13th, 2001

American Medical Systems (AMS) announced that the U.S. Food and Drug Administration has cleared the AMS SPARC Sling System for commercial marketing in the United States. The system is designed to offer a superior surgical approach to placing a sling for the treatment of female stress incontinence.

Sling procedures, which support the urethra, currently represent more than 40% of the total number of surgical procedures for incontinence.

"The SPARC system has been designed to provide a new, potentially safer and simpler option for the placement of a sling," said Doug Kohrs, AMS. "The SPARC system joins a rapidly growing AMS product line and will...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2001-09-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry